胰腺癌多式疗法:最先进的技术
Tia S Sutton1, Annmarie F Butare2, David B Meyer3
1Community Surgical Oncology Program, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
The American surgeon
|December 23, 2025
概括
多式疗法,包括新辅助疗法 (NAT),正在改善胰腺癌存活率. 这篇评论探讨了NAT的使用情况.
科学领域:
- 在瘤学瘤学.
- 手术瘤学手术瘤学
- 胃肠病学 胃肠病学
背景情况:
- 胰腺癌的治疗传统上依赖于手术切除.
- 多式疗法在过去二十年中使5年生存率从5%增加到10%.
- 辅助化学辐射得到了胰腺癌的强有力的临床证据的支持.
研究的目的:
- 在胰腺癌治疗中提供多式疗法的历史概述.
- 检查当前的临床问题和新兴策略,特别是胰腺癌的新辅助疗法 (NAT).
- 审查关于胰腺癌中NAT的最新证据和正在进行的临床试验.
主要方法:
- 关于胰腺癌多式疗法的文献综述.
- 对当前临床证据和关于新辅助疗法 (NAT) 的研究进行分析.
- 讨论正在进行的临床试验和胰腺癌治疗的未来方向.
主要成果:
- 多式疗法在胰腺癌存活率上显著改善.
- 新辅助疗法 (NAT) 是一种新兴的策略,有可能进一步改善患者的治疗结果.
- 强大的临床试验支持使用辅助化学辐射,而NAT正在积极调查中.
结论:
- 新辅助疗法 (NAT) 是胰腺癌多模式治疗的有前途的进展.
- 进一步的研究和正在进行的临床试验对于优化NAT协议和改善生存率至关重要.
- 多式疗法的发展,包括NAT,是促进胰腺癌治疗的关键.
相关概念视频
Chronic Pancreatitis II: Collaborative Care
282
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
282
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K


